导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.85% | 48/108 |
| 近一周 | -4.04% | 92/115 |
| 近一月 | -3.62% | 49/119 |
| 近一季 | -11.33% | 87/117 |
| 近半年 | -10.96% | 88/111 |
| 近一年 | -3.14% | 48/99 |
| 近两年 | 53.42% | 48/94 |
| 近三年 | 36.82% | 45/74 |
| 成立以来 | 151.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
9.53% 17/109 |
10.64% 50/119 |
- - |
- - |
| 2025 | 26.93% 57/108 |
15.62% 26/97 |
-0.86% 92/99 |
21.82% 34/104 |
-9.10% 59/108 |
| 2024 | 16.03% 39/97 |
-2.46% 60/89 |
8.15% 19/94 |
12.54% 33/97 |
-2.27% 53/97 |
| 2023 | -13.35% 49/93 |
2.16% 27/73 |
-5.46% 41/77 |
-5.60% 62/82 |
-4.95% 74/93 |
| 2022 | -26.84% 46/71 |
-27.02% 51/58 |
11.66% 7/62 |
-16.71% 43/68 |
7.78% 24/71 |
| 2021 | -19.56% 33/58 |
3.91% 93/312 |
6.25% 117/328 |
-17.88% 298/358 |
-11.27% 49/58 |
| 2020 | 19.97% 25/38 |
-10.09% 128/280 |
30.59% 32/295 |
-5.03% 266/299 |
7.58% 163/305 |
| 2019 | 26.16% 13/30 |
14.07% 60/258 |
-0.34% 186/268 |
0.17% 141/253 |
10.78% 54/266 |
| 2018 | -16.79% 15/28 |
- - |
- - |
- - |
-12.49% 141/241 |
| 2017 | 37.40% 5/20 |
- - |
- - |
- - |
- - |
| 2016 | -2.65% 13/17 |
- - |
- - |
- - |
- - |
| 2015 | -12.13% 12/16 |
- - |
- - |
- - |
- - |
| 2014 | 9.05% 29/99 |
- - |
- - |
- - |
- - |
| 2013 | 11.80% 23/70 |
- - |
- - |
- - |
- - |
| 2012 | 14.98% 16/51 |
- - |
- - |
- - |
- - |
| 2011 | -22.47% 17/27 |
- - |
- - |
- - |
- - |
| 2010 | -0.75% 7/9 |
- - |
- - |
- - |
- - |
| 2009 | 83.06% 1/9 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 摩根中国生物医药混合(QDII)A | 1.4779 | 17.64% |
| 摩根中国生物医药混合(QDII)C | 1.4554 | 17.49% |
| 南方港股医药行业混合发起(QDII)A | 1.3423 | 15.29% |
| 南方港股医药行业混合发起(QDII)C | 1.2936 | 15.12% |
| 东方红医疗创新混合(QDII)A | 0.8769 | 15.09% |
| 东方红医疗创新混合(QDII)C | 0.8725 | 13.42% |
| 万家全球成长一年持有期混合(QDII)A | 0.9681 | 12.64% |
| 万家全球成长一年持有期混合(QDII)C | 0.9395 | 12.46% |
| 长城港股医疗保健精选混合发起(QDII)A | 0.7593 | 8.70% |
| 富国医药精选混合(QDII)A | 0.9730 | 8.69% |
| 海富通中国海外混合 VS. 建信新兴市场混合(QDII)A(539002) |